Geron Corp (GERN) Stock Analysis
Verdict: AVOID
Imetelstat commercial ramp drives rapid top-line growth, but heavy debt and persistent cash burn keep dilution risk acute.
Investment score: 39/100
Analysis as of
Is Geron Corp stock worth reviewing? The TradeMates thesis
The TradeMates model evaluates Geron as an AVOID due to high leverage, ongoing cash burn of -$111.04M, and historical share dilution, which outweigh strong top-line revenue growth of $183.88M in FY2025.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 40/100 (weight 10%)
- Risk-Adjusted Return: 35/100 (weight 15%)
Geron Corp opportunities and risks
What speaks for GERN
- Rapid Imetelstat Commercial Revenue Scale
What speaks against GERN
- Persistent Operating Cash Burn and Debt Burden
Frequently asked questions about Geron Corp (GERN)
Is GERN stock a good investment?
The TradeMates model rates Geron Corp as AVOID with an investment score of 39/100. The TradeMates model evaluates Geron as an AVOID due to high leverage, ongoing cash burn of -$111.04M, and historical share dilution, which outweigh strong top-line revenue growth of $183.88M in FY2025. This is algorithmic model output, not personal investment advice.
Is GERN stock a buy?
The TradeMates model verdict for GERN is AVOID with an investment score of 39/100. Treat this as a model signal to review, not a personal buy recommendation.